https://www.heart-valve-surgery.com – Is the tricuspid valve still considered the “forgotten valve” in 2026? Why was it overlooked for so long, and what new catheter-based options can help patients with tricuspid regurgitation avoid open-heart surgery?
To answer these important questions, HeartValveSurgery.com founder Adam Pick spoke with Dr. Aakriti Gupta, Interventional Cardiologist at Cedars-Sinai in Los Angeles, California. In this educational video, Dr. Gupta explains why tricuspid disease was historically undertreated, what’s changed in recent years, and how newer transcatheter therapies may improve symptoms for select patients.
In this video, Dr. Gupta discusses:
- Why the tricuspid valve used to be called the “forgotten valve”
- Why many patients with primary tricuspid regurgitation are not ideal surgical candidates
- How catheter-based therapy through a vein in the groin is changing treatment options
- FDA-approved transcatheter therapies, including EVOQUE (replacement) and TriClip (repair)
- How echocardiogram and CT imaging help determine candidacy and the best approach
- What patients may feel after treatment (breathing better, walking better, less leg swelling)
- What the TRISCEND II trial showed and how it supported FDA approval
If you would like to schedule an appointment or seek a second opinion with Dr. Aakriti Gupta, please call (424) 622-8647 or visit:
https://www.heart-valve-surgery.com/interventional-cardiologist/dr-Aakriti-Gupta-Los+Angeles-California.php
To answer these important questions, HeartValveSurgery.com founder Adam Pick spoke with Dr. Aakriti Gupta, Interventional Cardiologist at Cedars-Sinai in Los Angeles, California. In this educational video, Dr. Gupta explains why tricuspid disease was historically undertreated, what’s changed in recent years, and how newer transcatheter therapies may improve symptoms for select patients.
In this video, Dr. Gupta discusses:
- Why the tricuspid valve used to be called the “forgotten valve”
- Why many patients with primary tricuspid regurgitation are not ideal surgical candidates
- How catheter-based therapy through a vein in the groin is changing treatment options
- FDA-approved transcatheter therapies, including EVOQUE (replacement) and TriClip (repair)
- How echocardiogram and CT imaging help determine candidacy and the best approach
- What patients may feel after treatment (breathing better, walking better, less leg swelling)
- What the TRISCEND II trial showed and how it supported FDA approval
If you would like to schedule an appointment or seek a second opinion with Dr. Aakriti Gupta, please call (424) 622-8647 or visit:
https://www.heart-valve-surgery.com/interventional-cardiologist/dr-Aakriti-Gupta-Los+Angeles-California.php
- Categoria
- Cardiology
Commenta per primo questo video.









